Biogen Inc at Stifel Virtual CNS Forum Transcript
This is going to be an interesting 45-minute discussion on a number of topics within the Biogen pipeline, with me is Diana Gallagher, Head of Clinical Development; and Stephanie Fradette, Head of the Neuromuscular Development unit. Maybe just -- you can each of you just sort of briefly introduce yourselves, how long you've been at Biogen, and then we can get right into it. I think I wanted to start with maybe talking about tau but we can cover a lot of stuff.
So Diana, do you want to go first?
&&
Sure. Thanks for having us, Paul. So my name is Diana Gallagher. I head several of the therapeutic areas of Biogen. So the Alzheimer's, the MS and the Immunology portfolios, and I've been at Biogen almost 11 years this month, yeah.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
